S.316 - Preserve Access to Affordable Generics Act

A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. view all titles (3)

All Bill Titles

  • Short: Preserve Access to Affordable Generics Act as introduced.
  • Official: A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. as introduced.
  • Short: Preserve Access to Affordable Generics Act as reported to senate.

This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.

This is a list of the blog posts on this bill rated most useful by the "My OpenCongress" community. You can help by clicking "Yes" or "No" next to each post where it reads, "Was this article useful?"
12/08/08
09.12.2008: Literarisches Bollwerk (Tageszeitung junge Welt)

5 Vgl. Gerrard Winstanley, Gleichheit im Reiche der Freiheit, Leipzig 1986, S. 316 6 Milton (wie Anm. 3), S. 70 (Pro populo Anglicano defensio secunda, 1654) 7 Milton, Das verlorene Paradies (deutsch/englisch), Frankfurt 2008, S. 322 ...

Source: junge Welt
11/26/08
Rez. NG: J. Lindenlaub: Die Finanzierung des Aufstiegs von Krupp ...

Auch in diesem Teil seiner Untersuchung liefert Lindenlaub interessante neue Erkenntnisse, wie die Tatsache, dass in der Verwaltung Krupps schon viele Aufgabebereiche moderner Controllingabteilungen abgedeckt wurden (S. 316-318). ...

11/03/08
„Bauchaufsatz“: Über den Antrieb meines Willens zu schreiben

... vorbestimmt sei und die Menschen sich dem Schicksal oder einer Macht hingeben müssten, sondern dass in diesen Zivilisationsprozess eingegriffen werden kann "aufgrund der Kenntnis ihrer ungeplanten Gesetzmäßigkeit." (Bd. II, S. 316).

09/21/08
Martha Muchow | Biographie

S. 316-321 und 346-352. Muchow, Martha (1925): Zur Problematik der Testpsychologie im allgemeinen und einiger Ordnungstests im besonderen. In: Stern, William (Hg.): Neue Beiträge zur Theorie und Praxis der Intelligenzprüfung. Leipzig. ...

06/12/08
Zehn Minuten Glück

(S.316). Das ist zum Heulen: Zum Heulen schön, dass er diese zehn Minuten erleben durfte. Zum Heulen schrecklich, dass er in 80 Jahren nur diese zehn Minuten getan hat, was er wirklich wollte. Und es ist zum Heulen, dass ich selbst die ...

Source: windhauch
04/20/08
Chirag Enterprise

S.316 allen cap screws as per drawings, s. S. Nut& lock nut(304q/316q), s. S. Washer. SS Spring washer(square& flat), s. S. Cheese/round head screwsas per is- 1366 a2 304q/as per bs - 450 a2 304q/s. S. Csk mach screw as per is - 1365 ...

04/06/08
RE:Facharbeit?

25), Müller-Wassermann (2000, S. 316 ff.), Furchtlos (2002, S. 23 f.) und Nachtigall (2002c, S. 234 – 236). Anders bei Wieser (1987, S. 43). o Beispiel 3: Nach Stein (1988, S. 25) zeichnet sich der Hochleistungssport ...

02/07/08
Talking about your Generation

Elias 1992, aaO, S. 316. Wenn auch im Hinblick auf die deutsche Geschichte formuliert, weist er damit bereits über das konkrete Beispiel hinaus. Denn diese Art von Konflikten existiert in jeder Gesellschaft (in unterschiedlicher ...

02/02/08
Brunhild Krueger über ein Buch von Robert Laughlin

Die Frage heute heißt (S. 316 - er stellt sie nicht selbst, sondern legt sie anderen in den Mund): „Ist Einstein überhaupt noch relevant?” Und Laughlin erklärt, daß genau das das Problem der Emergenz ist - es gibt wichtigeres: die ...

Source: Untitled
03/07/07
US pushes bill to promote competitive presence of generic drug manft.

The bipartisan Preserve Access to Affordable Generics Act (S. 316) would prohibit brand-name drug companies from exploiting a loophole in the Hatch-Waxman Act to pay generic drug companies to delay entry of new generic medicines into ...

Source: ipmINDs
03/06/07
praktischer Wertnihilismus

... so scheint es mir – wohl sogar deutliche und eindeutige Bekenntnisse zur Hochwertigkeit der Demokratie, ja: der freiheitlich-demokratischen Grundordnung, als „planmäßige Unterdrückung des kritischen Denkens“ (S. 316) abzulehnen. ...

02/26/07
Panel Passes Bipartisan Bill To Stop Payoffs That Delay Generic ...

The bipartisan Preserve Access to Affordable Generics Act (S. 316) would prohibit brand-name drug companies from exploiting a loophole in the Hatch-Waxman Act to pay generic drug companies to delay entry of new generic medicines into ...

02/23/07
Senate Panel Approves Bill To Ban Some Drug Pat...

The committee passed the bill—the "Preserve Access to Affordable Generics Act" (S. 316)—on February 15, clearing the measure for consideration by the full Senate. The bill's supporters say it would lead to more robust competition by ...

02/20/07
Senate Judiciary Committee Approves Bill That Would Prevent Drug ...

The Senate Judiciary Committee on Thursday approved legislation (S 316) that would prohibit brand-name pharmaceutical companies from paying generic drug companies to delay market introduction of generic competitors, CQ Today reports. ...

02/20/07
Senate Judiciary Committee Approves Bill That Would Prevent Drug ...

via Medical Buzz: The Senate Judiciary Committee on Thursday approved legislation (S 316) that would prohibit brand-name pharmaceutical companies from paying generic drug companies to delay market introduction of g...

02/20/07
Senate Judiciary Committee Approves Bill That Would Prevent Drug ...

The Senate Judiciary Committee on Thursday approved legislation S 316 that would prohibit brand45name pharmaceutical companies from paying generic drug companies to delay market introduction of generic competitors, CQ Today reports. ...

Source: Zapptor
02/20/07
Senate Judiciary Committee Approves Bill That Would Prevent Drug ...

via Medical Buzz: The Senate Judiciary Committee on Thursday approved legislation (S 316) that would prohibit brand-name pharmaceutical companies from paying generic drug companies to delay market introduction of g...

02/16/07
Panel Passes Bipartisan Bill To Stop Payoffs That Delay Generic ...

members, Senators Herb Kohl (D-Wisc.), Chuck Grassley (R-Iowa), Russ Feingold (D-Wisc.), and Charles Schumer (D-NY). ... To Affordable Generics Act (S. 316) Executive Business Meeting February 15, 2007 2007 Senator Kohl ...

02/15/07
Patent Reform is in the Air

It would add the following language: `Notwithstanding any other provision of law, no patent may be obtained for a nucleotide sequence, or its functions or correlations, or the naturally occurring products it specifies.’. S. 316, on the ...

Source: Freepress
02/15/07
Bill Aimed at Prohibiting Reverse Payment Settlements Clears ...

The Senate Judiciary Committee passed the "Preserve Access to Affordable Generics Act" (S. 316) today by unanimous consent. If enacted, the bill would prohibit "reverse payment" settlements of Hatch-Waxman litigation, ...

02/15/07
Patent Reform is in the Air

It would add the following language: `Notwithstanding any other provision of law, no patent may be obtained for a nucleotide sequence, or its functions or correlations, or the naturally occurring products it specifies.'. S. 316, on the ...

02/05/07
This Week's Senate Committee Schedule

S.316, to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. S.236, to require reports to Congress on ... S. 316: Preserve Access to Affordable Generics Act ...

02/03/07
Committee Hearing: Senate Judiciary

S. 316 : Preserve Access to Affordable Generics Act. S. 236 : Federal Agency Data Mining Reporting Act of 2007. S. Res. 36 : A resolution honoring women's health advocate Cynthia Boles Dailard. S. Res. 37 : A resolution designating ...

01/18/07
S. 316: Preserve Access to Affordable Generics Act (GovTrack.us)

A bill in the US Congress: A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.

Bill's Views

  • Today: 0
  • Past Seven Days: 10
  • All-Time: 927

-%

Users Support Bill

in favor / opposed
Write Your Senators
Track with MyOC

OpenCongress is a free and open-source joint project of two non-profit organizations, the Participatory Politics Foundation and the Sunlight Foundation.